Timothy Henrich, MD
Professor
Medicine
School of Medicine

My laboratory/research group specializes in immunmodulatory, cytoreductive chemotherapeutic and stem cell transplantation approaches to HIV-1 cure. We are also involved in the design and implementation of novel nano/microtechnologies and PET-based imaging approaches to characterize viral reservoirs.

Education & Training

Show all (5) Hide

• M.M.Sc. School of Medicine Harvard University 2013
• Infectious Disease Fellowship Massachusetts General Hospital and Brigham and Women's Hospital 2009
• Internal Medicine Residency Brigham and Women's Hospital 2007
• M.D. School of Medicine Yale University 2004
• B.A. Oberlin College 1996

Grants and Projects

Show all (10) Hide

• In Vivo PET Imaging of HIV Infection, NIH, 2020-2025
• Targeting Non Viral Markers of HIV Persistence, NIH, 2018-2023
• Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin, NIH, 2016-2021
• Single Cell Characterization of Latent HIV-1 Reservoirs, NIH, 2016-2021
• Biomarkers of CNS HIV Persistence, NIH, 2018-2021
• Measurement of Antibody Epitope Signatures by Peptide Microarrays to Determine Recency of HIV Infection, NIH, 2016-2019
• A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent Reservoirs, NIH, 2014-2017
• Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells, NIH, 2014-2017
• Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics, NIH, 2012-2017
• Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin, NIH, 2014-2016

Publications (155)

Top publication keywords:
CD4-Positive T-LymphocytesReceptors, CCR5Anti-Retroviral AgentsHIVKi-1 AntigenViral LoadHIV InfectionsCCR5 Receptor AntagonistsAnti-HIV AgentsHematopoietic Stem Cell TransplantationVirus LatencyRNA, ViralViremiaDNA, ViralHIV-1

• Plasma-based antigen persistence in the post-acute phase of COVID-19.
  The Lancet. Infectious diseases 2024 Peluso MJ, Swank ZN, Goldberg SA, Lu S, Dalhuisen T, Borberg E, Senussi Y, Luna MA, Chang Song C, Clark A, Zamora A, Lew M, Viswanathan B, Huang B, Anglin K, Hoh R, Hsue PY, Durstenfeld MS, Spinelli …
• Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease.
  medRxiv : the preprint server for health sciences 2024 Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso M, Martin J, Hecht F, Pilcher C, Cohen SE, Buchbinder…
• Systems analysis of innate and adaptive immunity in Long COVID.
  Seminars in immunology 2024 Peluso MJ, Abdel-Mohsen M, Henrich TJ, Roan NR
• Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2.
  Nature immunology 2024 Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, Andrew A, Young KC, Ma T, Hoh R, Anglin K, Huang B, Argueta U, Lopez M, Valdivieso D, Asare K, Deveau TM, Munter SE, Ibrahim R, Ständker L, Lu …
• Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study.
  Journal of medical virology 2024 Durstenfeld MS, Peluso MJ, Lin F, Peyser ND, Isasi C, Carton TW, Henrich TJ, Deeks SG, Olgin JE, Pletcher MJ, Beatty AL, Marcus GM, Hsue PY

Show all (150 more) Hide

• Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection.
  medRxiv : the preprint server for health sciences 2023 Peluso MJ, Swank ZN, Goldberg SA, Lu S, Dalhuisen T, Borberg E, Senussi Y, Luna MA, Song CC, Clark A, Zamora A, Lew M, Viswanathan B, Huang B, Anglin K, Hoh R, Hsue PY, Durstenfeld MS, Spinelli MA, …
• A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size.
  PLoS pathogens 2023 Dwivedi AK, Gornalusse GG, Siegel DA, Barbehenn A, Thanh C, Hoh R, Hobbs KS, Pan T, Gibson EA, Martin J, Hecht F, Pilcher C, Milush J, Busch MP, Stone M, Huang ML, Reppetti J, Vo PM, Levy CN, …
• The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.
  Journal of medical virology 2023 Buck AM, Deitchman AN, Takahashi S, Lu S, Goldberg SA, Bodansky A, Kung A, Hoh R, Williams MC, Kerbleski M, Maison DP, Deveau TM, Munter SE, Lombardo J, Wrin T, Petropoulos CJ, Durstenfeld MS, Hsue PY…
• Serotonin reduction in post-acute sequelae of viral infection.
  Cell 2023 Wong AC, Devason AS, Umana IC, Cox TO, Dohnalová L, Litichevskiy L, Perla J, Lundgren P, Etwebi Z, Izzo LT, Kim J, Tetlak M, Descamps HC, Park SL, Wisser S, McKnight AD, Pardy RD, Kim J, Blank N, …
• Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID With Exercise Capacity and Chronotropic Incompetence Among People With HIV.
  Journal of the American Heart Association 2023 Durstenfeld MS, Peluso MJ, Spinelli MA, Li D, Hoh R, Chenna A, Yee B, Winslow J, Petropoulos C, Gandhi M, Henrich TJ, Aras MA, Long CS, Deeks SG, Hsue PY
• Author Correction: SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
  Nature immunology 2023 Proal AD, VanElzakker MB, Aleman S, Bach K, Boribong BP, Buggert M, Cherry S, Chertow DS, Davies HE, Dupont CL, Deeks SG, Eimer W, Ely EW, Fasano A, Freire M, Geng LN, Griffin DE, Henrich TJ, Iwasaki …
• SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
  Nature immunology 2023 Proal AD, VanElzakker MB, Aleman S, Bach K, Boribong BP, Buggert M, Cherry S, Chertow DS, Davies HE, Dupont CL, Deeks SG, Eimer W, Ely EW, Fasano A, Freire M, Geng LN, Griffin DE, Henrich TJ, Iwasaki …
• SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency.
  American journal of epidemiology 2023 Takahashi S, Peluso MJ, Hakim J, Turcios K, Janson O, Routledge I, Busch MP, Hoh R, Tai V, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Greenhouse B, Rodríguez-Barraquer I
• Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019.
  The Journal of infectious diseases 2023 Durstenfeld MS, Peluso MJ, Kaveti P, Hill C, Li D, Sander E, Swaminathan S, Arechiga VM, Lu S, Goldberg SA, Hoh R, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Kelly JD, Glidden DV, Henrich TJ, …
• Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2.
  bioRxiv : the preprint server for biology 2023 Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, Andrew A, Young K, Ma T, Hoh R, Anglin K, Huang B, Argueta U, Lopez M, Valdivieso D, Asare K, Deveau TM, Munter SE, Ibrahim R, Ständker L, Lu S…
• Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19.
  medRxiv : the preprint server for health sciences 2023 Peluso MJ, Ryder D, Flavell R, Wang Y, Levi J, LaFranchi BH, Deveau TM, Buck AM, Munter SE, Asare KA, Aslam M, Koch W, Szabo G, Hoh R, Deswal M, Rodriguez A, Buitrago M, Tai V, Shrestha U, Lu S, …
• A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.
  Nature 2023 Augusto DG, Murdolo LD, Chatzileontiadou DSM, Sabatino JJ, Yusufali T, Peyser ND, Butcher X, Kizer K, Guthrie K, Murray VW, Pae V, Sarvadhavabhatla S, Beltran F, Gill GS, Lynch KL, Yun C, Maguire CT, …
• Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy.
  The Journal of infectious diseases 2023 Hastie E, Moser C, Sun X, Lennox J, Hsue PY, Bosch RJ, Deeks S, Meneses MV, Lederman MM, Hunt P, Henrich TJ, Marconi VC, Gianella S
• Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients.
  JCI insight 2023 Bodansky A, Wang CY, Saxena A, Mitchell A, Kung AF, Takahashi S, Anglin K, Huang B, Hoh R, Lu S, Goldberg SA, Romero J, Tran B, Kirtikar R, Grebe H, So M, Greenhouse B, Durstenfeld MS, Hsue PY, …
• Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC).
  eLife 2023 Mohandas S, Jagannathan P, Henrich TJ, Sherif ZA, Bime C, Quinlan E, Portman MA, Gennaro M, Rehman J, RECOVER Mechanistic Pathways Task Force
• Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies.
  Viruses 2023 Buck AM, Deveau TM, Henrich TJ, Deitchman AN
• Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIV.
  medRxiv : the preprint server for health sciences 2023 Durstenfeld MS, Peluso MJ, Spinelli MA, Li D, Hoh R, Gandhi M, Henrich TJ, Aras MA, Long CS, Deeks SG, Hsue PY
• MultiSero: An Open-Source Multiplex-ELISA Platform for Measuring Antibody Responses to Infection.
  Pathogens (Basel, Switzerland) 2023 Byrum JR, Waltari E, Janson O, Guo SM, Folkesson J, Chhun BB, Vinden J, Ivanov IE, Forst ML, Li H, Larson AG, Blackmon L, Liu Z, Wu W, Ahyong V, Tato CM, McCutcheon KM, Hoh R, Kelly JD, Martin JN, …
• The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms.
  medRxiv : the preprint server for health sciences 2023 Buck AM, Deitchman AN, Takahashi S, Lu S, Goldberg SA, Hoh R, Williams MC, Kerbleski M, Deveau TM, Munter SE, Lombardo J, Wrin T, Petropoulos CJ, Durstenfeld MS, Hsue PY, Kelly JD, Greenhouse B, …
• Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).
  eLife 2023 Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB, RECOVER Mechanistic Pathway Task Force
• Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID.
  medRxiv : the preprint server for health sciences 2023 Durstenfeld MS, Peluso MJ, Kaveti P, Hill C, Li D, Sander E, Swaminathan S, Arechiga VM, Lu S, Goldberg SA, Hoh R, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Kelly JD, Glidden DV, Henrich TJ, …
• Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients.
  medRxiv : the preprint server for health sciences 2023 Bodansky A, Wang CY, Saxena A, Mitchell A, Takahashi S, Anglin K, Huang B, Hoh R, Lu S, Goldberg SA, Romero J, Tran B, Kirtikar R, Grebe H, So M, Greenhouse B, Durstenfeld MS, Hsue PY, Hellmuth J, …
• Chronic viral coinfections differentially affect the likelihood of developing long COVID.
  The Journal of clinical investigation 2023 Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, Chan F, Lu S, Goldberg SA, Hoh R, Tai V, Torres L, Iyer NS, Deswal M, Ngo LH, Buitrago M, Rodriguez A, Chen JY, Yee BC, Chenna A, …
• Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection.
  bioRxiv : the preprint server for biology 2023 Dwivedi AK, Siegel DA, Thanh C, Hoh R, Hobbs KS, Pan T, Gibson EA, Martin J, Hecht F, Pilcher C, Milush J, Busch MP, Stone M, Huang ML, Levy CN, Roychoudhury P, Hladik F, Jerome KR, Henrich TJ, Deeks …
• Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID.
  The Journal of infectious diseases 2023 Peluso MJ, Mitchell A, Wang CY, Takahashi S, Hoh R, Tai V, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, Wilson MR, Greenhouse B, Deeks SG, DeRisi JL, Henrich TJ
• PP 4.19 – 00021 Impact of SARS-COV-2-Mediated CD4 T Cell Activation HIV DNA Persistence In Vivo.
  Journal of Virus Eradication 2022 T.-M. Deveau, M. Peluso, A. Buck, N. Kumar, T. Henrich
• 442. Clinical Outcomes of Checkpoint Inhibitor Therapy in People with HIV: A Single-Center Case Series.
  Open Forum Infectious Diseases 2022 Hannah M Sans, Benjamin Jones, Erin Isaza, Peter V Chin-Hong, Timothy J Henrich, Michael J Peluso
• Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.
  AIDS (London, England) 2022 Siegel DA, Thanh C, Wan E, Hoh R, Hobbs K, Pan T, Gibson EA, Kroetz DL, Martin J, Hecht F, Pilcher C, Martin M, Carrington M, Pillai S, Busch MP, Stone M, Levy CN, Huang ML, Roychoudhury P, Hladik F, …
• A common allele of HLA mediates asymptomatic SARS-CoV-2 infection.
  medRxiv : the preprint server for health sciences 2022 Augusto DG, Yusufali T, Sabatino JJ, Peyser ND, Murdolo LD, Butcher X, Murray V, Pae V, Sarvadhavabhatla S, Beltran F, Gill G, Lynch K, Yun C, Maguire C, Peluso MJ, Hoh R, Henrich TJ, Deeks SG, …
• Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling.
  JCI insight 2022 Giron LB, Peluso MJ, Ding J, Kenny G, Zilberstein NF, Koshy J, Hong KY, Rasmussen H, Miller GE, Bishehsari F, Balk RA, Moy JN, Hoh R, Lu S, Goldman AR, Tang HY, Yee BC, Chenna A, Winslow JW, …
• Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Spinelli MA, Peluso MJ, Lynch KL, Yun C, Glidden DV, Henrich TJ, Deeks SG, Gandhi M
• Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling.
  JCI insight 2022 Giron LB, Peluso MJ, Ding J, Kenny G, Zilberstein NF, Koshy J, Hong KY, Rasmussen H, Miller GE, Bishehsari F, Balk RA, Moy JN, Hoh R, Lu S, Goldman AR, Tang HY, Yee BC, Chenna A, Winslow JW, …
• Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID.
  medRxiv : the preprint server for health sciences 2022 Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, Chan F, Lu S, Goldberg SA, Hoh R, Tai V, Torres L, Iyer NS, Deswal M, Ngo LH, Buitrago M, Rodriguez A, Chen JY, Yee BC, Chenna A, …
• Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.
  AIDS (London, England) 2022 Peluso MJ, Spinelli MA, Deveau TM, Forman CA, Munter SE, Mathur S, Tang AF, Lu S, Goldberg SA, Arreguin MI, Hoh R, Tai V, Chen JY, Martinez EO, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Sette A, …
• Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies.
  Pathogens & immunity 2022 Peluso MJ, Anglin K, Durstenfeld MS, Martin JN, Kelly JD, Hsue PY, Henrich TJ, Deeks SG
• Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection.
  Neurology(R) neuroimmunology & neuroinflammation 2022 Peluso MJ, Sans HM, Forman CA, Nylander AN, Ho HE, Lu S, Goldberg SA, Hoh R, Tai V, Munter SE, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Martin JN, Kelly JD, Durstenfeld MS, Hsue PY, Hunt PW, …
• Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 Peluso MJ, Thomas IJ, Munter SE, Deeks SG, Henrich TJ
• Rapid sequential development and rupture of mycotic aneurysms within a period of days in a patient with graft-versus-host disease and angiotropic Scedosporium apiospermum infection.
  Surgical neurology international 2022 Budohoski KP, Raygor K, Cook D, Henrich T, Abla AA
• Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection.
  JCI insight 2022 Durstenfeld MS, Peluso MJ, Kelly JD, Win S, Swaminathan S, Li D, Arechiga VM, Zepeda V, Sun K, Shao S, Hill C, Arreguin MI, Lu S, Hoh R, Tai V, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Kornak J, …
• Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy.
  The Journal of clinical investigation 2022 Varco-Merth BD, Brantley W, Marenco A, Duell DD, Fachko DN, Richardson B, Busman-Sahay K, Shao D, Flores W, Engelman K, Fukazawa Y, Wong SW, Skalsky RL, Smedley J, Axthelm MK, Lifson JD, Estes JD, …
• CE-541-04 CARDIAC ARRHYTHMIAS IN POST-ACUTE SEQUELAE OF SARS-COV-2 INFECTION ASSESSED BY AMBULATORY RHYTHM MONITORING.
  Heart Rhythm 2022 Christopher Hill, Shreya Swaminathan, Danny Li, Michael J. Peluso, Timothy J. Henrich, Jeffrey N. Martin, Steven G. Deeks, Priscilla Y. Hsue, Matthew S. Durstenfeld
• COVID-19 in vaccinated versus unvaccinated hematologic malignancy patients.
  Transplant infectious disease : an official journal of the Transplantation Society 2022 DeVoe C, Pandey S, Shariff D, Arora S, Henrich TJ, Yokoe DS, Langelier CR, Servellita V, Chiu C, Miller S, Babik JM, Chin-Hong P, Fung M
• SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19.
  Annals of neurology 2022 Peluso MJ, Deeks SG, Mustapic M, Kapogiannis D, Henrich TJ, Lu S, Goldberg SA, Hoh R, Chen JY, Martinez EO, Kelly JD, Martin JN, Goetzl EJ
• First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody.
  Nature communications 2022 Beckford-Vera DR, Flavell RR, Seo Y, Martinez-Ortiz E, Aslam M, Thanh C, Fehrman E, Pardons M, Kumar S, Deitchman AN, Ravanfar V, Schulte B, Wu IK, Pan T, Reeves JD, Nixon CC, Iyer NS, Torres L, …
• Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19.
  Annals of clinical and translational neurology 2022 Apple AC, Oddi A, Peluso MJ, Asken BM, Henrich TJ, Kelly JD, Pleasure SJ, Deeks SG, Allen IE, Martin JN, Ndhlovu LC, Miller BL, Stephens ML, Hellmuth J
• Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement.
  Open forum infectious diseases 2021 Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, Fehrman EA, Torres L, Hernandez Y, Williams MC, Arreguin MI, Ngo LH, Deswal M, Munter SE, …
• Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery.
  International journal of behavioral medicine 2021 Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, Kelly JD, Martin JN, Henrich TJ, Deeks SG, Sauceda JA
• LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV.
  Open Forum Infectious Diseases 2021 Matthew A Spinelli, Michael J Peluso, Kara Lynch, Cassandra Yun, David V Glidden, Timothy J Henrich, Steve Deeks, Monica Gandhi
• Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
  The Journal of infectious diseases 2021 Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, Forman CA, Munter SE, Hoh R, Tai V, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Greenhouse B, Hunt PW, Hsue PY, Martin JN, Daniel Kelly …
• Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions.
  Translational research : the journal of laboratory and clinical medicine 2021 Peluso MJ, Donatelli J, Henrich TJ
• A High Percentage of People With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following Coronavirus Disease 2019 (COVID-19).
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Peluso MJ, Bakkour S, Busch MP, Deeks SG, Henrich TJ
• TNF-α inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines.
  AIDS (London, England) 2021 Claytor JD, Viramontes O, Conner S, Wen KW, Beck K, Chin-Hong PV, Henrich TJ, Peluso MJ
• SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency.
  medRxiv : the preprint server for health sciences 2021 Takahashi S, Peluso MJ, Hakim J, Turcios K, Janson O, Routledge I, Busch MP, Hoh R, Tai V, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Greenhouse B, Rodríguez-Barraquer I
• Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
  Cell reports 2021 Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L,…
• SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
  Science advances 2021 Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Donatelli J, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, …
• Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease.
  Open forum infectious diseases 2021 Peluso MJ, Munter SE, Lynch KL, Yun C, Torres L, Iyer NS, Donatelli J, Ryan L, Deitchman AN, Deeks SG, Rutishauser RL, Henrich TJ
• Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients.
  The Journal of clinical investigation 2021 Stock PG, Henrich TJ, Segev DL, Werbel WA
• Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records.
  Nature communications 2021 Routledge I, Epstein A, Takahashi S, Janson O, Hakim J, Duarte E, Turcios K, Vinden J, Sujishi K, Rangel J, Coh M, Besana L, Ho WK, Oon CY, Ong CM, Yun C, Lynch K, Wu AHB, Wu W, Karlon W, Thornborrow …
• multiSero: open multiplex-ELISA platform for analyzing antibody responses to SARS-CoV-2 infection.
  medRxiv : the preprint server for health sciences 2021 Byrum JR, Waltari E, Janson O, Guo SM, Folkesson J, Chhun BB, Vinden J, Ivanov IE, Forst ML, Li H, Larson AG, Wu W, Tato CM, McCutcheon KM, Peluso MJ, Henrich TJ, Deeks SG, Prakash M, Greenhouse B, …
• SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
  The lancet. HIV 2021 Spinelli MA, Lynch KL, Yun C, Glidden DV, Peluso MJ, Henrich TJ, Gandhi M, Brown LB
• Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.
  Nature biotechnology 2021 Elledge SK, Zhou XX, Byrnes JR, Martinko AJ, Lui I, Pance K, Lim SA, Glasgow JE, Glasgow AA, Turcios K, Iyer NS, Torres L, Peluso MJ, Henrich TJ, Wang TT, Tato CM, Leung KK, Greenhouse B, Wells JA
• Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study.
  medRxiv : the preprint server for health sciences 2021 Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, Kelly JD, Martin JN, Henrich TJ, Deeks SG, Sauceda JA
• Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19.
  medRxiv : the preprint server for health sciences 2021 Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, Fehrman EA, Torres L, Hernandez Y, Williams MC, Arreguin MI, Bautista JA, Ngo LH, Deswal M, …
• SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
  medRxiv : the preprint server for health sciences 2021 Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, …
• Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19.
  medRxiv : the preprint server for health sciences 2021 Peluso MJ, Deitchman AN, Torres L, Iyer NS, Nixon CC, Munter SE, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman E, Spinelli MA, Gandhi M, Trinh L, …
• Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations.
  Cells 2021 Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, Munter SE, Nixon CC, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Pulliam L
• Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco.
  Research square 2021 Routledge I, Epstein A, Takahashi S, Janson O, Hakim J, Duarte E, Turcios K, Vinden J, Sujishi K, Rangel J, Coh M, Besana L, Ho WK, Oon CY, Ong CM, Yun C, Lynch K, Wu AHB, Wu W, Karlon W, Thornborrow …
• Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo.
  Journal of virology 2021 Gramatica A, Schwarzer R, Brantley W, Varco-Merth B, Sperber HS, Hull PA, Montano M, Migueles SA, Rosenthal D, Hogan LE, Johnson JR, Packard TA, Grimmett ZW, Herzig E, Besnard E, Nekorchuk M, Hsiao F,…
• Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients.
  Journal of neurovirology 2021 Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, Greenhouse B, Martin JN, Chow FC, Deeks SG, Greene M, Miller BL, Annan W, Henrich TJ, Peluso MJ
• Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19.
  Journal of leukocyte biology 2021 Corley MJ, Pang APS, Dody K, Mudd PA, Patterson BK, Seethamraju H, Bram Y, Peluso MJ, Torres L, Iyer NS, Premeaux TA, Yeung ST, Chandar V, Borczuk A, Schwartz RE, Henrich TJ, Deeks SG, Sacha JB, …
• 969. TNF-alpha inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines.
  Open Forum Infectious Diseases 2020 Jennifer Claytor, Omar Viramontes, Stephanie Conner, Kwun Wah Wen, Kendall Beck, Timothy J Henrich, Peter Chin-Hong, Peter Chin-Hong, Michael J Peluso
• Treatment of immunocompromised COVID-19 patients with convalescent plasma.
  Transplant infectious disease : an official journal of the Transplantation Society 2020 Fung M, Nambiar A, Pandey S, Aldrich JM, Teraoka J, Freise C, Roberts J, Chandran S, Hays SR, Bainbridge E, DeVoe C, Roque Gardner A, Yokoe D, Henrich TJ, Babik JM, Chin-Hong P
• Total-Body PET Imaging in Infectious Diseases.
  PET clinics 2020 Henrich TJ, Jones T, Beckford-Vera D, Price PM, VanBrocklin HF
• A “false-positive” HIV test?.
  2020 Michael J. Peluso, Timothy J. Henrich
• Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community.
  Open Forum Infectious Diseases 2020 Ayesha Appa, Saki Takahashi, Isabel Rodriguez-Barraquer, Gabriel Chamie, Aenor Sawyer, Elias Duarte, Jill Hakim, Keirstinne Turcios, Joanna Vinden, Owen Janson, Aashish Manglik, Michael J Peluso, …
• Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community.
  Open forum infectious diseases 2020 Appa A, Takahashi S, Rodriguez-Barraquer I, Chamie G, Sawyer A, Duarte E, Hakim J, Turcios K, Vinden J, Janson O, Manglik A, Peluso MJ, Deeks SG, Henrich TJ, Torres L, Rodgers M, Hackett J, Chiu C, …
• Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2020 Henrich TJ, Schreiner C, Cameron C, Hogan LE, Richardson B, Rutishauser RL, Deitchman AN, Chu S, Rogers R, Thanh C, Gibson EA, Zarinsefat A, Bakkour S, Aweeka F, Busch MP, Liegler T, Baker C, Milush J…
• Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.
  medRxiv : the preprint server for health sciences 2020 Elledge SK, Zhou XX, Byrnes JR, Martinko AJ, Lui I, Pance K, Lim SA, Glasgow JE, Glasgow AA, Turcios K, Iyer N, Torres L, Peluso MJ, Henrich TJ, Wang TT, Tato CM, Leung KK, Greenhouse B, Wells JA
• Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community.
  medRxiv : the preprint server for health sciences 2020 Appa A, Takahashi S, Rodriguez-Barraquer I, Chamie G, Sawyer A, Consortium C, Duarte E, Hakim J, Turcios K, Vinden J, Janson O, Manglik A, Peluso MJ, Deeks SG, Henrich TJ, Torres L, Rodgers M, Hackett…
• From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation.
  Current HIV/AIDS reports 2020 Prator CA, Donatelli J, Henrich TJ
• Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2020 Fung M, Chiu CY, DeVoe C, Doernberg SB, Schwartz BS, Langelier C, Henrich TJ, Yokoe D, Davis J, Hays SR, Chandran S, Kukreja J, Ng D, Prostko J, Taylor R, Reyes K, Bainbridge E, Bond A, Chin-Hong P, …
• Outcomes of immunomodulatory and biologic therapy in people living with HIV.
  AIDS (London, England) 2020 Peluso MJ, Chen J, Munter S, Reed A, Teraoka J, Eshun-Wilson I, Henrich TJ, Chin-Hong PV
• Biosensing: Tunable Fano-Resonant Metasurfaces on a Disposable Plastic-Template for Multimodal and Multiplex Biosensing (Adv. Mater. 19/2020).
  Advanced Materials 2020 Rajib Ahmed, Mehmet Ozgun Ozen, Merve Goksin Karaaslan, Cecilia A. Prator, Cassandra Thanh, Shreya Kumar, Leonel Torres, Nikita Iyer, Sadie Munter, Sarka Southern, Timothy J. Henrich, Fatih Inci, …
• Tunable Fano-Resonant Metasurfaces on a Disposable Plastic-Template for Multimodal and Multiplex Biosensing.
  Advanced materials (Deerfield Beach, Fla.) 2020 Ahmed R, Ozen MO, Karaaslan MG, Prator CA, Thanh C, Kumar S, Torres L, Iyer N, Munter S, Southern S, Henrich TJ, Inci F, Demirci U
• Circulating CD30+CD4+ T Cells Increase Before Human Immunodeficiency Virus Rebound After Analytical Antiretroviral Treatment Interruption.
  The Journal of infectious diseases 2020 Prator CA, Thanh C, Kumar S, Pan T, Peluso MJ, Bosch R, Jones N, Milush JM, Bakkour S, Stone M, Busch MP, Deeks SG, Hunt PW, Henrich TJ
• Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy.
  JCI insight 2020 Peluso MJ, Bacchetti P, Ritter KD, Beg S, Lai J, Martin JN, Hunt PW, Henrich TJ, Siliciano JD, Siliciano RF, Laird GM, Deeks SG
• Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1.
  Journal of virus eradication 2020 Peluso MJ, Thanh C, Prator CA, Hogan LE, Arechiga VM, Stephenson S, Norris PJ, Di Germanio C, Fuchs D, Zetterberg H, Deeks SG, Gisslén M, Price RW, Henrich TJ
• HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility.
  Journal of virology 2020 Registre L, Moreau Y, Ataca ST, Pulukuri S, Henrich TJ, Lin N, Sagar M
• Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.
  AIDS (London, England) 2019 Winston A, Antinori A, Cinque P, Fox HS, Gisslen M, Henrich TJ, Letendre S, Persaud D, Price RW, Spudich S
• OP 3.1 Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy.
  Journal of virus eradication 2019 M. Peluso, P. Bacchetti, K. Ritter, S. Beg, P. Hunt, T. Henrich, J. Siliciano, R. Siliciano, G. Laird, S. Deeks
• OP 4.2 Characterising ‘exceptional’ control among HIV elite controllers.
  Journal of virus eradication 2019 M. Peluso, P. Burbelo, S. Kumar, S. Munter, R. Hoh, S. Lee, P. Hunt, R. Rutishauser, T. Henrich, S. Deeks
• Rapid development of HIV elite control in a patient with acute infection.
  BMC infectious diseases 2019 Morley D, Lambert JS, Hogan LE, De Gascun C, Redmond N, Rutishauser RL, Thanh C, Gibson EA, Hobbs K, Bakkour S, Busch MP, Farrell J, McGetrick P, Henrich TJ
• Seeing Is Believing: Nuclear Imaging of HIV Persistence.
  Frontiers in immunology 2019 Henrich TJ, Hsue PY, VanBrocklin H
• CD32-RNA Co-localizes with HIV-RNA in CD3+ Cells Found within Gut Tissues from Viremic and ART-Suppressed Individuals.
  Pathogens & immunity 2019 Vásquez JJ, Aguilar-Rodriguez BL, Rodriguez L, Hogan LE, Somsouk M, McCune JM, Deeks SG, Laszik ZG, Hunt PW, Henrich TJ
• Second example reported of a stem-cell transplant in the clinic leading to HIV remission.
  Nature 2019 Henrich TJ
• Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma.
  Blood advances 2018 Wang CC, Thanh C, Gibson EA, Ball-Burack M, Hogan LE, Descours B, Jones N, Carvidi AB, Munter S, Bakkour S, Busch MP, Milush JM, Deeks SG, Henrich TJ
• Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection.
  Annals of oncology : official journal of the European Society for Medical Oncology 2018 Scully EP, Rutishauser RL, Simoneau CR, Delagrèverie H, Euler Z, Thanh C, Li JZ, Hartig H, Bakkour S, Busch M, Alter G, Marty FM, Wang CC, Deeks SG, Lorch J, Henrich TJ
• Progress towards obtaining an HIV cure: slow but sure.
  Current opinion in HIV and AIDS 2018 Henrich TJ, Lelièvre JD
• NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation.
  Blood advances 2018 Hogan LE, Körner C, Hobbs K, Simoneau CR, Thanh C, Gibson EA, Palmer CD, Pandit A, Marty FM, Kuritzkes DR, Jost S, Ritz J, Henrich TJ
• Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.
  PloS one 2018 Hogan LE, Hanhauser E, Hobbs KS, Palmer CD, Robles Y, Jost S, LaCasce AS, Abramson J, Hamdan A, Marty FM, Kuritzkes DR, Henrich TJ
• Dolutegravir intensification and HIV persistence: 3 + 1 = 3.
  The lancet. HIV 2018 Henrich TJ
• Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30.
  PLoS pathogens 2018 Hogan LE, Vasquez J, Hobbs KS, Hanhauser E, Aguilar-Rodriguez B, Hussien R, Thanh C, Gibson EA, Carvidi AB, Smith LCB, Khan S, Trapecar M, Sanjabi S, Somsouk M, Stoddart CA, Kuritzkes DR, Deeks SG, …
• Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In Situ.
  The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2018 Vasquez JJ, Hussien R, Aguilar-Rodriguez B, Junger H, Dobi D, Henrich TJ, Thanh C, Gibson E, Hogan LE, McCune J, Hunt PW, Stoddart CA, Laszik ZG
• HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
  PLoS medicine 2017 Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, …
• Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.
  The Journal of infectious diseases 2017 Henrich TJ, Hobbs KS, Hanhauser E, Scully E, Hogan LE, Robles YP, Leadabrand KS, Marty FM, Palmer CD, Jost S, Körner C, Li JZ, Gandhi RT, Hamdan A, Abramson J, LaCasce AS, Kuritzkes DR
• Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.
  PLoS pathogens 2017 Hill AL, Rosenbloom DIS, Goldstein E, Hanhauser E, Kuritzkes DR, Siliciano RF, Henrich TJ
• High-throughput Characterization of HIV-1 Reservoir Reactivation Using a Single-Cell-in-Droplet PCR Assay.
  EBioMedicine 2017 Yucha RW, Hobbs KS, Hanhauser E, Hogan LE, Nieves W, Ozen MO, Inci F, York V, Gibson EA, Thanh C, Shafiee H, El Assal R, Kiselinova M, Robles YP, Bae H, Leadabrand KS, Wang S, Deeks SG, Kuritzkes DR, …
• A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.
  Virology 2017 Charlins P, Schmitt K, Remling-Mulder L, Hogan LE, Hanhauser E, Hobbs KS, Hecht F, Deeks SG, Henrich TJ, Akkina R
• Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.
  The Journal of infectious diseases 2017 Henrich TJ, Deeks SG, Pillai SK
• International AIDS Society global scientific strategy: towards an HIV cure 2016.
  Nature medicine 2016 Deeks SG, Lewin SR, Ross AL, Ananworanich J, Benkirane M, Cannon P, Chomont N, Douek D, Lifson JD, Lo YR, Kuritzkes D, Margolis D, Mellors J, Persaud D, Tucker JD, Barre-Sinoussi F, International AIDS…
• INTERACTIVE MEDICAL CASE. A Woman with Dyspnea and Altered Mental Status.
  The New England journal of medicine 2016 Patel KP, Vaidya A, Gibson CJ, Henrich TJ, Lyons JL
• Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring.
  Advanced drug delivery reviews 2016 Lifson MA, Ozen MO, Inci F, Wang S, Inan H, Baday M, Henrich TJ, Demirci U
• Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.
  PLoS pathogens 2016 Hill AL, Rosenbloom DI, Goldstein E, Hanhauser E, Kuritzkes DR, Siliciano RF, Henrich TJ
• Evolution of coreceptor utilization to escape CCR5 antagonist therapy.
  Virology 2016 Zhang J, Gao X, Martin J, Rosa B, Chen Z, Mitreva M, Henrich T, Kuritzkes D, Ratner L
• Ethics of ART interruption after stem-cell transplantation.
  The lancet. HIV 2016 Sugarman J, Lewin SR, Henrich TJ, Rasmussen TA
• PP 10.1 Predicting determinants of long-term HIV control with gene therapy strategies.
  Journal of virus eradication 2015 A.L. Hill, L. Hu, L.E. Hogan, M.A. Nowak, T.J. Henrich
• Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV.
  Journal of virus eradication 2015 A.L. Hill, D.I.S. Rosenbloom, D.R. Kuritzkes, R.F. Siliciano, T.J. Henrich
• CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy.
  The Journal of infectious diseases 2015 Henrich TJ, Hanhauser E, Harrison LJ, Palmer CD, Romero-Tejeda M, Jost S, Bosch RJ, Kuritzkes DR
• Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1.
  Open forum infectious diseases 2015 Rosenbloom DI, Elliott O, Hill AL, Henrich TJ, Siliciano JM, Siliciano RF
• Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics.
  Proceedings of the National Academy of Sciences of the United States of America 2015 Inci F, Filippini C, Baday M, Ozen MO, Calamak S, Durmus NG, Wang S, Hanhauser E, Hobbs KS, Juillard F, Kuang PP, Vetter ML, Carocci M, Yamamoto HS, Takagi Y, Yildiz UH, Akin D, Wesemann DR, Singhal A…
• Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva.
  Scientific reports 2015 Shafiee H, Kanakasabapathy MK, Juillard F, Keser M, Sadasivam M, Yuksekkaya M, Hanhauser E, Henrich TJ, Kuritzkes DR, Kaye KM, Demirci U
• HIV eradication: is cord blood the answer?
  The lancet. HIV 2015 Henrich TJ
• Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.
  AIDS (London, England) 2015 Henrich TJ, Hanhauser E, Hu Z, Stellbrink HJ, Noah C, Martin JN, Deeks SG, Kuritzkes DR, Pereyra F
• Emerging technologies for point-of-care management of HIV infection.
  Annual review of medicine 2014 Shafiee H, Wang S, Inci F, Toy M, Henrich TJ, Kuritzkes DR, Demirci U
• Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.
  Annals of internal medicine 2014 Henrich TJ, Hanhauser E, Marty FM, Sirignano MN, Keating S, Lee TH, Robles YP, Davis BT, Li JZ, Heisey A, Hill AL, Busch MP, Armand P, Soiffer RJ, Altfeld M, Kuritzkes DR
• Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion.
  AIDS (London, England) 2014 Al-Hajjar SH, Frayha HH, Al-Hazmi M, Batawi R, McIntosh K, Sax PE, Al-Thawadi S, Al-Jumaah S, Busch MP, Hanhauser E, Kuritzkes DR, Li JZ, Henrich TJ
• Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study.
  Open forum infectious diseases 2014 Henrich TJ, McLaren PJ, Rao SS, Lin NH, Hanhauser E, Giguel F, Gulick RM, Ribaudo H, de Bakker PI, Kuritzkes DR
• Nanostructured optical photonic crystal biosensor for HIV viral load measurement.
  Scientific reports 2014 Shafiee H, Lidstone EA, Jahangir M, Inci F, Hanhauser E, Henrich TJ, Kuritzkes DR, Cunningham BT, Demirci U
• HIV-1 persistence in CD4+ T cells with stem cell-like properties.
  Nature medicine 2014 Buzon MJ, Sun H, Li C, Shaw A, Seiss K, Ouyang Z, Martin-Gayo E, Leng J, Henrich TJ, Li JZ, Pereyra F, Zurakowski R, Walker BD, Rosenberg ES, Yu XG, Lichterfeld M
• Early treatment and HIV-1 reservoirs: a stitch in time?
  The Journal of infectious diseases 2013 Henrich TJ, Gandhi RT
• Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation.
  The Journal of infectious diseases 2013 Henrich TJ, Hu Z, Li JZ, Sciaranghella G, Busch MP, Keating SM, Gallien S, Lin NH, Giguel FF, Lavoie L, Ho VT, Armand P, Soiffer RJ, Sagar M, Lacasce AS, Kuritzkes DR
• HIV-1 entry inhibitors: recent development and clinical use.
  Current opinion in virology 2013 Henrich TJ, Kuritzkes DR
• Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mL.
  PloS one 2012 Henrich TJ, Wood BR, Kuritzkes DR
• Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR.
  Journal of virological methods 2012 Henrich TJ, Gallien S, Li JZ, Pereyra F, Kuritzkes DR
• HIV-2 encephalitis: case report and literature review.
  AIDS patient care and STDs 2012 Wood BR, Klein JP, Lyons JL, Milner DA, Phillips RE, Schutten M, Folkerth RD, Ciarlini P, Henrich TJ, Johnson JA
• Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.
  Antimicrobial agents and chemotherapy 2012 Henrich TJ, Lewine NR, Lee SH, Rao SS, Berro R, Gulick RM, Moore JP, Tsibris AM, Kuritzkes DR
• SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.
  PloS one 2011 Tsibris AM, Pal U, Schure AL, Veazey RS, Kunstman KJ, Henrich TJ, Klasse PJ, Wolinsky SM, Kuritzkes DR, Moore JP
• Impact of age, gender, and pregnancy on syphilis screening using the Captia Syphilis-G assay.
  Sexually transmitted diseases 2011 Henrich TJ, Yawetz S
• HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.
  Journal of virology 2011 Putcharoen O, Lee SH, Henrich TJ, Hu Z, Vanichanan J, Coakley E, Greaves W, Gulick RM, Kuritzkes DR, Tsibris AM
• Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.
  Journal of acquired immune deficiency syndromes (1999) 2010 Henrich TJ, Tsibris AM, Lewine NR, Konstantinidis I, Leopold KE, Sagar M, Kuritzkes DR
• Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions.
  The Journal of infectious diseases 2010 Henrich TJ, Li JZ, Felsenstein D, Kotton CN, Plenge RM, Pereyra F, Marty FM, Lin NH, Grazioso P, Crochiere DM, Eggers D, Kuritzkes DR, Tsibris AM
• Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010 Henrich TJ, Ribaudo HJ, Kuritzkes DR
• Infectious granulomatous dermatitis associated with Rothia mucilaginosa bacteremia: A case report.
  The American Journal of dermatopathology 2010 Morgan EA, Henrich TJ, Jarell AD, Shieh WJ, Zaki SR, Marty FM, Thorner AR, Milner DA, Velazquez EF
• Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature.
  Transplant infectious disease : an official journal of the Transplantation Society 2009 Henrich TJ, Marty FM, Milner DA, Thorner AR
• Clinical risk factors for severe Clostridium difficile-associated disease.
  Emerging infectious diseases 2009 Henrich TJ, Krakower D, Bitton A, Yokoe DS
• Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009 Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR
• Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics.
  Journal of community health 2008 Henrich TJ, Lauder N, Desai MM, Sofair AN
• Transposon-mediated enhancer trapping in medaka.
  Gene 2003 Grabher C, Henrich T, Sasado T, Arenz A, Wittbrodt J, Furutani-Seiki M
• Geographic dynamics of viral encephalitis in Thailand.
  Microbes and infection 2003 Henrich TJ, Hutchaleelaha S, Jiwariyavej V, Barbazan P, Nitatpattana N, Yoksan S, Gonzalez JP
• Hantaan virus antibody prevalence in rodent populations of several provinces of northeastern Thailand.
  Tropical medicine & international health : TM & IH 2002 Nitatpattana N, Henrich T, Palabodeewat S, Tangkanakul W, Poonsuksombat D, Chauvancy G, Barbazan P, Yoksan S, Gonzalez JP